Marshall T. Schreeder
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Research Studies
Most-Cited Works
- → Hepatitis B in Homosexual Men: Prevalence of Infection and Factors Related to Transmission(1982)189 cited
- → Randomized controlled trial of irinotecan drug‐eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver‐limited metastasis(2015)151 cited
- → Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.(1997)134 cited
- → A novel five-antibody immunohistochemical test for subclassification of lung carcinoma(2009)91 cited
- → Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia(2019)87 cited
- → Carcinoma of unknown primary site(2000)84 cited
- → Phase I study of single-agent CC-292, a highly selective Brutons tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia(2016)83 cited
- → Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial(2012)76 cited
- → Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity(2019)72 cited
- → A phase 1/2 trial of ublituximab, a novel anti‐ CD 20 monoclonal antibody, in patients with B‐cell non‐Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab(2017)72 cited